DE GIGLIO, ANDREA

DE GIGLIO, ANDREA  

DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE  

Ricercatori a tempo determinato  

Mostra records
Risultati 1 - 20 di 66 (tempo di esecuzione: 0.05 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Effective retreatment with osimertinib in CNS-relapsed epidermal growth factor receptor-mutant non-small cell lung cancer patient following resection and adjuvant osimertinib Di Federico A.; De Giglio A.; Sperandi F.; Melotti B.; Ardizzoni A.; Gelsomino F. 2024-01-01 ANTI-CANCER DRUGS - 1.01 Articolo in rivista -
From Development to Place in Therapy of Lorlatinib for the Treatment of ALK and ROS1 Rearranged Non-Small Cell Lung Cancer (NSCLC) Fabbri L.; Di Federico A.; Astore M.; Marchiori V.; Rejtano A.; Seminerio R.; Gelsomino F.; De Gi...glio A. 2024-01-01 DIAGNOSTICS - 1.01 Articolo in rivista diagnostics-14-00048-v2.pdf
Navigating challenges in EGFR exon 20 insertions: The PAPILLON trial unravels the promise of amivantamab-chemotherapy De Giglio A.; Di Federico A.; Gariazzo E.; Metro G. 2024-01-01 MED - 1.01 Articolo in rivista -
Adjuvant crizotinib treatment selected by patient-derived organoids in a patient with stage IIIA adenocarcinoma with novel LRRTM4-ALK fusion: a case report Li B.; Jia Z.; Huang Z.; Xue J.; Wang Y.; Guo C.; Si X.; Chen Z.; Li J.; Chen R.; Bie Z.; De Gigl...io A.; Christopoulos P.; Liang N.; Li S. 2023-01-01 TRANSLATIONAL LUNG CANCER RESEARCH - 1.01 Articolo in rivista 80018-PB6-4841-R2.pdf2322.zip
Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non‐Small‐Cell Lung Cancer Riudavets M.; Auclin E.; Mosteiro M.; Dempsey N.; Majem M.; Prelaj A.; Lopez-Castro R.; Bosch-Bar...rera J.; Pilotto S.; Escalera E.; Tagliamento M.; Mosquera J.; Zalcman G.; Aboubakar Nana F.; Ponce S.; Albarran-Artahona V.; Dal Maso A.; Spotti M.; Mielgo X.; Mussat E.; Reyes R.; Benitez J.-C.; Lupinacci L.; Duchemann B.; De Giglio A.; Blaquier J.B.; Audigier-Valette C.; Scheffler M.; Nadal E.; Lopes G.; Signorelli D.; Garcia-Campelo R.; Menis J.; Bluthgen V.; Campayo M.; Recondo G.; Besse B.; Mezquita L.; Planchard D. 2023-01-01 CLINICAL LUNG CANCER - 1.01 Articolo in rivista -
Bone-specific response according to MDA criteria predicts immunotherapy efficacy among advanced non-small cell lung cancer (NSCLC) patients De Giglio A.; Deiana C.; Di Federico A. 2023-01-01 JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY - 1.01 Articolo in rivista De_Giglio_2023.pdf432_2022_4120_MOESM1_ESM.png
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians Raschi, Emanuel; Rossi, Simone; De Giglio, Andrea; Fusaroli, Michele; Burgazzi, Flavio; Rinaldi, ...Rita; Potena, Luciano 2023-01-01 DRUG SAFETY - 1.01 Articolo in rivista Raschi et al., Drug Safety Cardiotoxicity ICI 2023.pdf40264_2023_1320_MOESM1_ESM.pdf
Clinical Utility and Application of Liquid Biopsy Genotyping in Lung Cancer: A Comprehensive Review Nigro M.C.; Marchese P.V.; Deiana C.; Casadio C.; Galvani L.; Di Federico A.; De Giglio A. 2023-01-01 LUNG CANCER: TARGETS AND THERAPY - 1.01 Articolo in rivista -
Neutrophil-to-Lymphocyte Ratio (NLR) in NSCLC, Gastrointestinal, and Other Solid Tumors: Immunotherapy and Beyond Mosca M.; Nigro M.C.; Pagani R.; De Giglio A.; Di Federico A. 2023-01-01 BIOMOLECULES - 1.01 Articolo in rivista biomolecules-13-01803.pdf
Peripheral nervous system adverse events associated with immune checkpoint inhibitors Rossi S.; Gelsomino F.; Rinaldi R.; Muccioli L.; Comito F.; Di Federico A.; De Giglio A.; Lambert...i G.; Andrini E.; Mollica V.; D'Angelo R.; Baccari F.; Zenesini C.; Madia P.; Raschi E.; Cortelli P.; Ardizzoni A.; Guarino M. 2023-01-01 JOURNAL OF NEUROLOGY - 1.01 Articolo in rivista Rossi_JN_2023.pdf
Predictors of Survival to Immunotherapy and Chemoimmunotherapy in Non-Small Cell Lung Cancer: A Meta-Analysis Di Federico, Alessandro; De Giglio, Andrea; Gelsomino, Francesco; Sperandi, Francesca; Melotti, B...arbara; Ardizzoni, Andrea 2023-01-01 JOURNAL OF THE NATIONAL CANCER INSTITUTE - 1.01 Articolo in rivista -
Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer Di Federico A.; Ricciotti I.; Favorito V.; Michelina S.V.; Scaparone P.; Metro G.; De Giglio A.; ...Pecci F.; Lamberti G.; Ambrogio C.; Ricciuti B. 2023-01-01 CURRENT ONCOLOGY REPORTS - 1.01 Articolo in rivista -
The expanding scenario of advanced non-small-cell lung cancer between emerging evidence and clinical tasks De Giglio A.; Ricciuti B.; Metro G. 2023-01-01 DRUGS IN CONTEXT - 1.01 Articolo in rivista dic.2022-11-4.pdf
Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease Metro G.; De Giglio A.; Ricciuti B.; Siringo M.; Marinelli D.; Gelibter A.; Pecci F.; Berardi R.;... Cantini L.; Di Federico A.; Andrini E.; Mosca M.; Lamberti G.; Brambilla M.; Mountzios G. 2022-01-01 DRUGS IN CONTEXT - 1.01 Articolo in rivista -
Advanced non-small-cell lung cancer: how to manage non-oncogene disease De Giglio A.; Di Federico A.; Deiana C.; Ricciuti B.; Brambilla M.; Metro G. 2022-01-01 DRUGS IN CONTEXT - 1.01 Articolo in rivista dic.2022-2-4.pdf
Atezolizumab-bevacizumab plus Y-90 TARE for the treatment of hepatocellular carcinoma: preclinical rationale and ongoing clinical trials Di Federico A.; Rizzo A.; Carloni R.; De Giglio A.; Bruno R.; Ricci D.; Brandi G. 2022-01-01 EXPERT OPINION ON INVESTIGATIONAL DRUGS - 1.01 Articolo in rivista -
Challenges in the management of advanced NSCLC among Italian oncologists: a 2019 national survey unfolds regional disparities De Giglio A.; Orlando V.; Andrini E.; Ricciuti B.; Lamberti G.; Chiari R. 2022-01-01 TUMORI - 1.01 Articolo in rivista -
Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations Riudavets M.; Auclin E.; Mosteiro M.; Dempsey N.; Majem M.; Lobefaro R.; Lopez-Castro R.; Bosch-B...arrera J.; Pilotto S.; Escalera E.; Tagliamento M.; Mosquera J.; Zalcman G.; Aboubakar-Nana F.; Ponce S.; Dal Maso A.; Spotti M.; Mielgo-Rubio X.; Mussat E.; Reyes R.; Benitez J.-C.; Lupinacci L.; Duchemann B.; De Giglio A.; Blaquier J.; Audigier-Valette C.; Scheffler M.; Nadal E.; Lopes G.; Signorelli D.; Garcia-Campelo R.; Menis J.; Bluthgen V.; Campayo M.; Recondo G.; Besse B.; Planchard D.; Mezquita L. 2022-01-01 EUROPEAN JOURNAL OF CANCER - 1.01 Articolo in rivista -
Exploring immune checkpoint inhibition in combination with anti-angiogenic therapy for patients with EGFR- or ALK-positive advanced non-small cell lung cancer De Giglio A.; Di Federico A.; Metro G. 2022-01-01 TRANSLATIONAL LUNG CANCER RESEARCH - 1.01 Articolo in rivista -
Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes Di Federico, Alessandro; De Giglio, Andrea; Gelsomino, Francesco; De Biase, Dario; Giunchi, Franc...esca; Palladini, Arianna; Sperandi, Francesca; Melotti, Barbara; Ardizzoni, Andrea 2022-01-01 CANCERS - 1.01 Articolo in rivista cancers-14-03472-v2.pdfcancers-14-03472-s001.zip